NCT02874222View on ClinicalTrials.gov

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2023

Study Completion Date

May 1, 2024

Conditions
Breast Cancer
Interventions
OTHER

surveys completed by subject

Cohort study designed to validate previously identified associations between 10 specific SNPs and discontinuation of treatment with AIs due to the development of MSS among women with breast cancer.

Trial Locations (1)

92134

Naval Medical Center San Diego, San Diego

All Listed Sponsors
collaborator

Alliance for Clinical Trials in Oncology

OTHER

lead

United States Naval Medical Center, San Diego

FED

NCT02874222 - A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms | Biotech Hunter | Biotech Hunter